These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1769440)

  • 21. Indomethacin but not metoprolol reduces exercise-induced albumin excretion rate in type 1 diabetic patients with microalbuminuria.
    Rudberg S; Sätterström G; Dahlqvist R; Dahlquist G
    Diabet Med; 1993 Jun; 10(5):460-4. PubMed ID: 8334827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diurnal blood pressure pattern may predict the increase of urinary albumin excretion in normotensive normoalbuminuric type 1 diabetes mellitus patients.
    Lengyel Z; Rosivall L; Németh C; Tóth LK; Nagy V; Mihály M; Kammerer L; Vörös P
    Diabetes Res Clin Pract; 2003 Dec; 62(3):159-67. PubMed ID: 14625130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between urinary excretion of sodium and dopamine in type 1 diabetic patients with an without microalbuminuria.
    Patrick AW; Jeffrey RF; Collier A; Clarke BF; Lee MR
    Diabet Med; 1990 Jan; 7(1):53-6. PubMed ID: 2137064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved metabolic control does not alter the charge-dependent glomerular filtration of albumin in uncomplicated type 1 (insulin-dependent) diabetes.
    Kverneland A; Welinder B; Feldt-Rasmussen B; Deckert T
    Diabetologia; 1988 Sep; 31(9):708-10. PubMed ID: 3234644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy.
    Gruden G; Cavallo-Perin P; Olivetti C; Repetti E; Sivieri R; Bruno A; Pagano G
    Diabetologia; 1995 Oct; 38(10):1218-22. PubMed ID: 8690175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microalbuminuria in NIDDM is caused by increased excretion of unmodified albumin.
    Ishibashi F
    Diabetes; 1996 Jun; 45(6):731-5. PubMed ID: 8635645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal evaluation of the renal clearance of glycated albumin in the diabetic rat.
    Layton GJ; Allen TJ; Jerums G
    Diabetes Res Clin Pract; 1990 Mar; 8(3):221-6. PubMed ID: 2340793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Albumin excretion and renal haemodynamic response to physical exercise in normal and diabetic man.
    Vittinghus E; Mogensen CE
    Scand J Clin Lab Invest; 1981 Nov; 41(7):627-32. PubMed ID: 7339864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus.
    Hopper AH; Tindall H; Urquhart S; Davies JA
    Horm Metab Res; 1987 May; 19(5):201-3. PubMed ID: 3583229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal urinary albumin excretion in recently diagnosed type 1 diabetic patients.
    Lind B; Jensen T; Feldt-Rasmussen B; Deckert T
    Diabet Med; 1989 Nov; 6(8):682-4. PubMed ID: 2532101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Size- and charge selectivity of glomerular filtration in Type 1 (insulin-dependent) diabetic patients with and without albuminuria.
    Deckert T; Kofoed-Enevoldsen A; Vidal P; Nørgaard K; Andreasen HB; Feldt-Rasmussen B
    Diabetologia; 1993 Mar; 36(3):244-51. PubMed ID: 8462774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal blood pressure response to exercise in normoalbuminuric insulin dependent diabetic patients.
    Cavan D; O'Donnell MJ; Parkes A; Lewis H; Lawson N; Chapman J; Barnett AH
    J Hum Hypertens; 1991 Feb; 5(1):21-6. PubMed ID: 1828271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin.
    Nielsen S; Schmitz A; Bacher T; Rehling M; Ingerslev J; Mogensen CE
    Diabetologia; 1999 Jan; 42(1):60-7. PubMed ID: 10027580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension and renal selectivity properties in diabetic microalbuminuria.
    Ghiggeri GM; Candiano G; Ginevri F; Garberi A; Acerbo S; Perfumo F; Gusmano R
    Nephrol Dial Transplant; 1990; 5 Suppl 1():66-8. PubMed ID: 2129464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iloprost decreases urinary albumin excretion rate in patients with diabetic nephropathy.
    Shindo H; Tawata M; Yokomori N; Hosaka Y; Ohtaka M; Onaya T
    Diabetes Res Clin Pract; 1993; 21(2-3):115-22. PubMed ID: 7505737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triphasic changes in selectivity with increasing proteinuria in type 1 and type 2 diabetes.
    Jerums G; Allen TJ; Cooper ME
    Diabet Med; 1989 Dec; 6(9):772-9. PubMed ID: 2533035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise testing as a long-term predictor of the development of microalbuminuria in normoalbuminuric IDDM patients.
    O'Brien SF; Watts GF; Powrie JK; Shaw KM
    Diabetes Care; 1995 Dec; 18(12):1602-5. PubMed ID: 8722059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary secretion of albumin in type 1 (insulin-dependent) diabetes.
    Fisher BM; Lamey PJ; Sweeney D; Beeley JA; Spooner RJ; Frier BM
    Diabetes Res Clin Pract; 1991 Feb; 11(2):117-9. PubMed ID: 2022176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to predict nephropathy in type 1 diabetic patients.
    Dash R; Torffvit O
    Scand J Urol Nephrol; 2003; 37(5):437-42. PubMed ID: 14594696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction.
    Schalkwijk CG; Ter Wee PM; Stehouwer CD
    Ann N Y Acad Sci; 2005 Jun; 1043():662-70. PubMed ID: 16037290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.